About: Neurovax

An Entity of Type: drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Neurovax is a vaccine designed to treat patients with multiple sclerosis. Developed by Immune Response BioPharma, Inc. it is currently in phase II clinical trials. Neurovax is designed to stimulate FOXP3+ regulatory T-cells that can then suppress the autoreactive T-cells in some patients.

Property Value
dbo:abstract
  • Neurovax is a vaccine designed to treat patients with multiple sclerosis. Developed by Immune Response BioPharma, Inc. it is currently in phase II clinical trials. Neurovax is designed to stimulate FOXP3+ regulatory T-cells that can then suppress the autoreactive T-cells in some patients. (en)
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 12136761 (xsd:integer)
dbo:wikiPageLength
  • 1445 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 851129563 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Neurovax is a vaccine designed to treat patients with multiple sclerosis. Developed by Immune Response BioPharma, Inc. it is currently in phase II clinical trials. Neurovax is designed to stimulate FOXP3+ regulatory T-cells that can then suppress the autoreactive T-cells in some patients. (en)
rdfs:label
  • Neurovax (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License